EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Concomitant percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation

Julius Fischer iD, Julius Steffen iD, Tobias Arlart, Magda Haum, Sarah Gschwendtner, Philipp M Doldi, Konstantinos Rizas, Hans Theiss, Daniel Braun iD, Martin Orban, Sven Peterß, Jörg Hausleiter und 2 weitere

Catheterization and Cardiovascular Interventions · 2024

DOI: 10.1002/ccd.30927 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2024. Verfasst von Julius Fischer und 13 weiteren Autor:innen. Beteiligte Einrichtung: Medizinische Klinik und Poliklinik I, LMU Klinikum, Ludwig-Maximilians-Universität (LMU), Munich, Germany. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Percutaneous Coronary Intervention, Aortic Valve Stenosis, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients undergoing transcatheter aortic valve implantation (TAVI) frequently have coronary artery disease requiring percutaneous coronary intervention (PCI). Usually, PCI and TAVI are performed in two separate procedures and current studies are investigating potential benefits regarding the order. However, the two interventions may also be performed simultaneously, thereby limiting the risk associated with repeated vascular access. Data evaluating benefit and harm of concomitant procedures are scarce.

Aims

Therefore, this study aimed to evaluate concomitant PCI (coPCI) in TAVI patients regarding Valve Academic Research Consortium 3 (VARC‐3) endpoints and long‐term mortality.

Methods

A total of 2233 consecutive TAVI patients from the EVERY‐VALVE registry were analyzed according to the VARC‐3 endpoint definitions. A total of 274 patients had undergone TAVI and concomitant PCI (coPCI group). They were compared to 226 TAVI patients who had received PCI within 60 days before TAVI in a stepwise approach (swPCI group) and to the remaining 1733 TAVI patients who had not undergone PCI recently (noPCI group).

Results

Overall median age was 81.4 years, median Society of Thoracic Surgeons score was 4.0%. Patients in the coPCI and in the swPCI group were predominantly male with reduced left‐ventricular ejection fraction. Rates of VARC‐3 composite endpoints technical success and 30‐day device success were comparable between all three groups. Mortality rates at 3 years after TAVI were similar (coPCI, 34.2% vs. swPCI, 31.9% vs. noPCI, 34.0% p = 0.84). Conclusions coPCI during TAVI seems comparable in a retrospective analysis. Compared to a stepwise approach, it has similar rates of composite endpoints technical success and device success as well as long‐term mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementPercutaneous Coronary InterventionAortic Valve StenosisHeart Valve Prosthesis ImplantationHumansMaleAged, 80 and overFemaleRetrospective StudiesStroke VolumeTreatment OutcomeVentricular Function, LeftAortic ValveRisk Factors

Stichwörter der Autor:innen

AKIPCITAVIVARC-3aortic stenosisbleeding

Autor:innen und Institutionen

  • Medizinische Klinik und Poliklinik I, LMU Klinikum, Ludwig-Maximilians-Universität (LMU), Munich, Germany.
  • Munich Heart Alliance, German Centre for Cardiovascular Research (DZHK), Munich, Germany.
  • Zentrale Notaufnahme und Aufnahmestation, Campus Benjamin Franklin (CBF), Charité Universitätsmedizin, Berlin, Germany.
  • Department of Heart Surgery, LMU Klinikum, Ludwig-Maximilians-Universität (LMU), Munich, Germany.

ORCID-Profile: Julius Fischer, Julius Steffen, Daniel Braun, Simon Deseive

Zitieren

APA

Fischer, J., Steffen, J., Arlart, T., Haum, M., Gschwendtner, S., Doldi, P. M., Rizas, K., Theiss, H., Braun, D., Orban, M., Peterß, S., Hausleiter, J., Massberg, S., & Deseive, S. (2024). Concomitant percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30927

Vancouver

Fischer J, Steffen J, Arlart T, Haum M, Gschwendtner S, Doldi PM, et al. Concomitant percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.30927

BibTeX
@article{Fischer2024,
  author = {Fischer, Julius and Steffen, Julius and Arlart, Tobias and Haum, Magda and Gschwendtner, Sarah and Doldi, Philipp M and Rizas, Konstantinos and Theiss, Hans and Braun, Daniel and Orban, Martin and Peterß, Sven and Hausleiter, Jörg and Massberg, Steffen and Deseive, Simon},
  title = {Concomitant percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2024},
  doi = {10.1002/ccd.30927}
}
Kostenlos starten →